Related Experiment Video
Updated: Mar 4, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Zero-Contrast Percutaneous Renal Denervation Guided by Multimodal Image Fusion
Ruisong Ma1, Xiaoli Dong1, Lili Zhang1
1Department of Cardiology, Hainan General Hospital, Haikou, China; Hainan Affiliated Hospital of Hainan Medical University, Haikou, China.
Renal denervation (RDN) can be performed without contrast agents, offering a safer alternative for patients with kidney or heart issues. This zero-contrast RDN approach avoids risks associated with contrast dyes, improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Nephrology
- Interventional Radiology
Background:
- Resistant hypertension and uncontrolled hypertension are significant clinical challenges.
- Renal denervation (RDN) is an established second-line therapy.
- Conventional RDN uses contrast agents, posing risks for patients with renal or cardiac insufficiency.
Related Concept Videos
Imaging Studies VII: Vascular Imaging
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies II: Ultrasonography

